The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2023

Filed:

Nov. 14, 2018
Applicant:

Arcellx, Inc, Germantown, MD (US);

Inventors:

David M. Hilbert, Germantown, MD (US);

Jeffrey S. Swers, Germantown, MD (US);

David William Lafleur, Washington, DC (US);

Assignee:

Arcellx, Inc., Germantown, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61P 35/00 (2006.01); A61K 38/17 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 38/1774 (2013.01); A61P 35/00 (2018.01); C07K 14/7051 (2013.01); C07K 16/289 (2013.01); C07K 16/2866 (2013.01); C07K 16/2878 (2013.01); C07K 16/32 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2319/33 (2013.01);
Abstract

Provided herein are multi-functional chimeric antigen receptor (CAR)-based compositions and their use in directing immune responses to target cells. The compositions have uses that include treating hyperproliferative disorders such as cancer. The provided methods generally include the use of a CAR cell in combination with an Adapter. The Adapter confers the ability to modulate, alter, and/or redirect CAR cell-mediated immune response in vitro and in vivo. In some embodiments, the CAR cell comprises a genetic modification to reduce or eliminate the expression of a targeted antigenic determinant.


Find Patent Forward Citations

Loading…